cytarabine has been researched along with Cholera Infantum in 54 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (22.22) | 18.7374 |
| 1990's | 19 (35.19) | 18.2507 |
| 2000's | 9 (16.67) | 29.6817 |
| 2010's | 11 (20.37) | 24.3611 |
| 2020's | 3 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Abu-Sbeih, H; Ali, FS; Curry, JL; Foo, WC; Ge, PS; Luo, W; Neelapu, SS; Okhuysen, PC; Richards, DM; Tang, T; Wang, Y; Westin, JR | 1 |
| Gershman, G; Getachew, R; Gotesman, M; Lasky, JL; Lee, S; Morales, S; Panosyan, EH; Zangwill, KM | 1 |
| Amberg, S; Bokemeyer, C; Christine Wilke, A; Chromik, J; Deppermann, U; Fiedler, W; Ganser, A; Heuser, M; Janning, M; Kebenko, M; Kranich, AL; Modemann, F; Schlipfenbacher, V; Serve, H; Theile, S; Thol, F | 1 |
| Galinsky, I; Hoang, CJ; McBride, A; Newman, MJ; Paul, S; Relias, V; Ryan, JC; Saneeymehri, S; Stanislaus, G; Tobin, J | 1 |
| Altman, JK; Broun, ER; Carroll, MP; Karp, JE; Kaufmann, SH; Ketterling, RP; Lazarus, HM; Litzow, MR; Luger, SM; Paietta, EM; Pratz, KW; Rowe, JM; Rybka, WB; Tallman, MS; Tun, HW; Wang, XV; Zhang, Y | 1 |
| Ammerlaan, RA; Chu, IW; Cornelissen, JJ; Deenik, W; Falkenburg, JH; Janssen, JJ; Kersten, MJ; Ossenkoppele, GJ; Schattenberg, A; Schipperus, M; Sinnige, HA; Smit, WM; Sonneveld, P; Thielen, N; Valk, PJ; van der Holt, B; van Marwijk Kooy, R; Verhoef, GE | 1 |
| Bekele, N; Borthakur, G; Estey, E; Jabbour, EJ; Kantarjian, H; Keating, MJ; O'Brien, S; Plunkett, WK; Ravandi-Kashani, F; Tsimberidou, AM | 1 |
| Amadori, S; de Witte, T; Halkes, CJ; Karrasch, M; Marie, JP; Meert, L; Meloni, G; Muus, P; Rapion, J; Suciu, S; Vignetti, M; Willemze, R | 1 |
| Benton, CB; Borthakur, G; Dara, S; Franklin, AR; Garcia-Manero, G; Jabbour, E; Kantarjian, H; Kwari, M; O'Brien, S; Pierce, SR; Ravandi, F; Rytting, M; Thomas, DA; Yang, H | 1 |
| Bar-Natan, M; Douer, D; Herscovici, C; Itchaki, G; Raanani, P; Ram, R; Shpilberg, O; Tallman, MS; Wolach, O; Yeshurun, M | 1 |
| Imada, K; Kitagawa, T; Mori, M; Onaka, T; Yonezawa, A | 1 |
| Ambrosetti, A; Balzarotti, M; Binder, M; Cavalli, F; Cwynarski, K; Deckert, M; Fabbri, A; Ferrari, A; Ferreri, AJ; Finke, J; Fox, CP; Gørløv, JS; Hemmaway, C; Hertenstein, B; Hess, G; Illerhaus, G; Johnson, P; Keller, U; Krause, SW; Levis, A; Linton, KM; Panse, J; Pisani, F; Politi, LS; Ponzoni, M; Pukrop, T; Pulczynski, E; Reni, M; Rosée, PL; Roth, A; Rudà, R; Schmoll, HJ; Schorb, E; Stilgenbauer, S; Torri, V; Tucci, A; Zucca, E | 1 |
| Brandwein, JM; Gupta, V; Howson-Jan, K; Leber, BF; MacAlpine, K; Minden, MD; Moore, M; Schimmer, AD; Schuh, AC; Wright, J; Yee, KW | 1 |
| Hawks, RG; Meza, JL; Post-White, JE; Sacks, N; Seibel, NL; Smith, LM; Withycombe, JS | 1 |
| Bowen, D; Burnett, AK; Cahalin, P; Craig, J; Hills, RK; Hunter, A; Kell, J; McMullin, MF; Milligan, D; Russell, N; Wheatley, K; Yin, J | 1 |
| Agha, M; Boyiadzis, M; Duggal, S; Hou, JZ; Im, A; Lin, Y; McLaughlin, B; Raptis, A; Redner, R; Smith, C | 1 |
| Aulitzky, W; Bodenstein, H; Clemens, M; Ehninger, G; Illmer, T; Neubauer, A; Repp, R; Schaich, M; Schäkel, U; Soucek, S; Wandt, H | 1 |
| Abbrederis, K; Apfelbeck, U; Baldinger, C; Buder, R; Burgstaller, S; Duba, C; Eisterer, W; Fiegl, M; Fridrik, M; Gastl, G; Geissler, D; Greil, R; Hausmaninger, H; Hilbe, W; Köck, L; Krieger, O; Kühr, T; Lang, A; Lin, W; Linkesch, W; Lutz, D; Michlmayr, G; Pont, J; Seewann, H; Thaler, J; Zabernigg, A | 1 |
| Bangaru, BS; Choi, SW; Finlay, JL; Wu, CD | 1 |
| Akin, U; Haluk, K; Hamdi, A; Ismet, A; Meral, B; Osman, I | 1 |
| Aung, L; Kirk, RC; Liang, S; Quah, TC; Tan, RM; Yeoh, AE | 1 |
| Atkins, H; Bence-Bruckler, I; Bredeson, C; Huebsch, L; Leger, C; McDiarmid, S; Sabloff, M; Zhang, H | 1 |
| Ebeling, P; Metz, K; Moritz, T; Müller, S; Nowrousian, MR; Passon, J; Schütt, P; Seeber, S; Welt, A | 1 |
| Aitkens, S; Belanger, G; Benoit, B; Dennery, J; Grahovac, Z; Hugenholtz, H; Peterson, E; Richard, MT; Russell, N; Stewart, DJ | 1 |
| Howell, SB; Pfeifle, CE | 1 |
| Abramson, N; Jones, GT | 1 |
| Breithaupt, H; Eckhardt, T; Löffler, H; Pralle, H; Schick, J; von Hattingberg, M | 1 |
| Mehta, J; Philpott, N; Powles, R; Treleaven, J | 1 |
| Arnold, R; Aul, C; Büchner, T; Diedrich, H; Faak, T; Fabry, U; Fischer, K; Fonatsch, C; Freund, M; Fuhr, HG; Gassmann, W; Gökbuget, N; Gramatzki, M; Heil, G; Heinze, B; Heyll, A; Hiddemann, W; Hoelzer, D; Hossfeld, D; Ittel, TH; Koch, P; Kolbe, K; Kuse, R; Löffler, H; Ludwig, WD; Maschmeyer, G; Messerer, D; Metzner, B; Rieder, H; Schadeck-Gressel, C; Strohscheer, I; Thiel, E; Uberla, K; Völkers, B; Weiss, A | 1 |
| Mempel, K; Pfetsch, M; Reiter, A; Riehm, H; Schrappe, M; Schwab, G; Welte, K | 1 |
| Bishop, JF; Bradstock, K; Cobcroft, R; Enno, A; Fox, R; Garson, OM; Gillett, A; Herrmann, R; Joshua, D; Juneja, S; Lowenthal, RM; Matthews, JP; Page, F; Szer, J; Van Der Weyden, M; Wolf, MM; Young, GA | 1 |
| Emmanoulides, C; Iastrebner, MC; Lee, M; Naeim, F; Schiller, G | 1 |
| Bernáldez-Ríos, R; Espinoza-Hernández, L; Fajardo-Gutíerrez, A; Martínez-García, MC; Mejía-Arangure, JM; Rodríguez-Zepeda, MC | 1 |
| Hiraoka, A; Karasuno, T; Kitamura, K; Miyawaki, S; Naoe, T; Ohnishi, K; Ohno, R; Takeshita, A; Takeuchi, M; Tobita, T; Ueda, R; Yanagi, M | 1 |
| Azuma, E; Higashigawa, M; Hirayama, M; Hori, H; Ido, M; Kawasaki, H; Sakurai, M | 1 |
| Ahn, C; Akman, S; Chow, W; Doroshow, JH; Leong, L; Margolin, K; Morgan, RJ; Raschko, J; Shibata, S; Somlo, G; Tetef, M | 1 |
| Camera, A; Catalano, L; Picardi, M; Rotoli, B; Selleri, C | 1 |
| Kuraishi, Y; Masaoka, T; Mizoguchi, H; Ogawa, M; Okabe, K; Saito, H; Sampi, K; Takemoto, Y; Tamura, K | 1 |
| Berinstein, NL; Franssen, E; Haq, R; Sawka, CA | 1 |
| Ahmed, T; Baskind, P; Darzynkiewicz, Z; Feldman, EJ; Goff, H; Pozzuoli, M; Santos, S; Seiter, K; Traganos, F | 1 |
| Dias, MA; Saral, R; Slavin, RE | 1 |
| Pizzo, PA; Walsh, TJ | 1 |
| Djuric, L; Jeremic, B; Mijatovic, L | 1 |
| Dölken, G; Fauser, AA; Herbst, EW; Kreisel, W | 1 |
| Tjon A Tham, RT; Vlasveld, LT; Willemze, R | 1 |
| Egeler, RM; Heymans, HS; Schipper, ME | 1 |
| Arthur, KA; Dhawan, RK; Kufe, DW; Mayer, RJ; Spriggs, DR; Stone, RM | 1 |
| Barnett, MJ; Bragman, K; Dhaliwal, HS; Lister, TA; Malpas, JS; Prentice, HG; Shannon, MS | 1 |
| Durie, BG; Garewal, H; Greenberg, B | 1 |
| Asou, N; Kawano, F; Matsuoka, Y; Tajima, H; Takatsuki, K | 1 |
| Ettinger, LJ; Jones, GR | 1 |
| Duffy, TP | 1 |
| Blumenschein, GR; Buzdar, AU; Feldman, LD | 1 |
| Anderson, J; Green, MR; Schilsky, RL | 1 |
2 review(s) available for cytarabine and Cholera Infantum
| Article | Year |
|---|---|
A Case of Langerhans Cell Histiocytosis With Multifocal, Single-System GI Tract Involvement and Literature Review.
Topics: Adult; Antimetabolites, Antineoplastic; Cytarabine; Female; Gastrointestinal Diseases; Histiocytosis, Langerhans-Cell; Humans; Prognosis; Young Adult | 2020 |
Gastrointestinal involvement in Langerhans' cell histiocytosis (Histiocytosis X): a clinical report of three cases.
Topics: Cyclophosphamide; Cytarabine; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Histiocytosis, Langerhans-Cell; Humans; Infant; Male; Prednisone; Vincristine | 1990 |
26 trial(s) available for cytarabine and Cholera Infantum
| Article | Year |
|---|---|
A Phase II study of selinexor plus cytarabine and idarubicin in patients with relapsed/refractory acute myeloid leukaemia.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytarabine; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Gastrointestinal Diseases; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Hydrazines; Idarubicin; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Middle Aged; Progression-Free Survival; Recurrence; Salvage Therapy; Triazoles | 2020 |
Glasdegib plus low-dose cytarabine for acute myeloid leukemia: Practical considerations from advanced practitioners and pharmacists.
Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Cytarabine; Drug Interactions; Female; Gastrointestinal Diseases; Hematologic Diseases; Humans; Leukemia, Myeloid, Acute; Male; Pharmacists; Phenylurea Compounds; Physicians | 2021 |
A randomized trial of three novel regimens for recurrent acute myeloid leukemia demonstrates the continuing challenge of treating this difficult disease.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cytarabine; Disease-Free Survival; Etoposide; Female; Flavonoids; Follow-Up Studies; Gastrointestinal Diseases; Hematologic Diseases; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Piperidines; Recurrence; Remission Induction; Salvage Therapy; Sirolimus; Topotecan; Tumor Lysis Syndrome | 2019 |
High-dose imatinib versus high-dose imatinib in combination with intermediate-dose cytarabine in patients with first chronic phase myeloid leukemia: a randomized phase III trial of the Dutch-Belgian HOVON study group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Cytarabine; Disease-Free Survival; Early Termination of Clinical Trials; Female; Gastrointestinal Diseases; Hematologic Diseases; Humans; Imatinib Mesylate; Infections; Kaplan-Meier Estimate; Leukemia, Myeloid, Chronic-Phase; Male; Middle Aged; Pain; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Sample Size; Treatment Outcome; Young Adult | 2013 |
A phase I study of fludarabine, cytarabine, and oxaliplatin therapy in patients with relapsed or refractory acute myeloid leukemia.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Cytarabine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gastrointestinal Diseases; Humans; Hyperbilirubinemia; Leukemia, Myeloid, Acute; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Remission Induction; Salvage Therapy; Treatment Outcome; Vidarabine; Young Adult | 2014 |
Clofarabine in combination with a standard remission induction regimen (cytosine arabinoside and idarubicin) in patients with previously untreated intermediate and bad-risk acute myelogenous leukemia (AML) or high-risk myelodysplastic syndrome (HR-MDS): p
Topics: Adenine Nucleotides; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleosides; Clofarabine; Consolidation Chemotherapy; Cytarabine; Fatigue; Female; Gastrointestinal Diseases; Humans; Hydroxyurea; Hyperbilirubinemia; Idarubicin; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Remission Induction; Risk; Treatment Outcome | 2014 |
Safety and clinical activity of 5-aza-2'-deoxycytidine (decitabine) with or without Hyper-CVAD in relapsed/refractory acute lymphocytic leukaemia.
Topics: Adolescent; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Bone Marrow; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Decitabine; Dexamethasone; DNA Methylation; DNA, Neoplasm; Doxorubicin; Drug Administration Schedule; Female; Gastrointestinal Diseases; Humans; Hyperglycemia; Infusions, Intravenous; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Remission Induction; Salvage Therapy; Vincristine; Young Adult | 2014 |
Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial.
Topics: Acute Kidney Injury; Anemia; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Chemical and Drug Induced Liver Injury; Combined Modality Therapy; Comparative Effectiveness Research; Cytarabine; Death, Sudden; Denmark; Dexamethasone; Disease-Free Survival; Female; Follow-Up Studies; Gastrointestinal Diseases; Germany; Heart Injuries; Hematopoietic Stem Cell Transplantation; Humans; Hyperglycemia; Induction Chemotherapy; Infections; Intraocular Lymphoma; Italy; Kaplan-Meier Estimate; Lymphoma, B-Cell; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Mucositis; Neurotoxicity Syndromes; Neutropenia; Optic Nerve Neoplasms; Poisoning; Radiotherapy, Adjuvant; Remission Induction; Rituximab; Stroke; Switzerland; Thiotepa; Thrombocytopenia; Thrombosis; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; United Kingdom | 2016 |
A phase I study of tipifarnib combined with conventional induction and consolidation therapy for previously untreated patients with acute myeloid leukemia aged 60 years and over.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Drug-Related Side Effects and Adverse Reactions; Gastrointestinal Diseases; Humans; Leukemia, Myeloid, Acute; Maximum Tolerated Dose; Middle Aged; Quinolones; Remission Induction | 2009 |
The addition of arsenic trioxide to low-dose Ara-C in older patients with AML does not improve outcome.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Chemical and Drug Induced Liver Injury; Comorbidity; Cytarabine; Disease-Free Survival; Early Termination of Clinical Trials; Female; Gastrointestinal Diseases; Heart Diseases; Humans; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Acute; Male; Middle Aged; Oxides; Remission Induction; Treatment Outcome | 2011 |
Fludarabine and cytarabine in patients with relapsed acute myeloid leukemia refractory to initial salvage therapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemical and Drug Induced Liver Injury; Cytarabine; Etoposide; Female; Gastrointestinal Diseases; Hematologic Diseases; Humans; Karyotype; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Neoplasms, Second Primary; Recurrence; Remission Induction; Salvage Therapy; Vidarabine | 2012 |
Intensified double induction therapy with high dose mitoxantrone, etoposide, m-amsacrine and high dose ara-C for elderly acute myeloid leukemia patients aged 61-65 years.
Topics: Acute Disease; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chemical and Drug Induced Liver Injury; Cytarabine; Disease-Free Survival; Etoposide; Female; Gastrointestinal Diseases; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Myeloid; Life Tables; Male; Middle Aged; Mitoxantrone; Neoplasm Proteins; Neutropenia; Remission Induction; Survival Analysis; Treatment Outcome | 2002 |
A randomized study comparing interferon (IFN alpha) plus low-dose cytarabine and interferon plus hydroxyurea (HU) in early chronic-phase chronic myeloid leukemia (CML).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Female; Gastrointestinal Diseases; Hematologic Diseases; Humans; Hydroxyurea; Interferon-alpha; Leukemia, Myeloid, Chronic-Phase; Life Tables; Male; Middle Aged; Nervous System Diseases; Recombinant Proteins; Treatment Outcome | 2003 |
Mitoxantrone and cytosine arabinoside in previously untreated adult patients with acute non-lymphocytic leukemia.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Cytarabine; Disease-Free Survival; Female; Gastrointestinal Diseases; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Remission Induction; Treatment Outcome | 1996 |
Outpatient autologous hematopoietic stem cell transplantation for patients with relapsed follicular lymphoma.
Topics: Adult; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Cytarabine; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Gastrointestinal Diseases; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Follicular; Male; Melphalan; Middle Aged; Neutropenia; Podophyllotoxin; Retrospective Studies; Transplantation Conditioning; Transplantation, Autologous | 2006 |
Ifosfamide, etoposide, cytarabine, and dexamethasone as salvage treatment followed by high-dose cyclophosphamide, melphalan, and etoposide with autologous peripheral blood stem cell transplantation for relapsed or refractory lymphomas.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Drug Resistance, Neoplasm; Etoposide; Female; Follow-Up Studies; Gastrointestinal Diseases; Hodgkin Disease; Humans; Ifosfamide; Kaplan-Meier Estimate; Lymphoma; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Neutropenia; Peripheral Blood Stem Cell Transplantation; Recurrence; Remission Induction; Salvage Therapy; Sepsis; Survival Rate; Transplantation, Autologous; Treatment Outcome | 2007 |
Idarubicin, high-dose cytarabine and etoposide for remission induction in therapy-related acute myeloid leukemia.
Topics: Acute Disease; Adult; Anemia, Refractory, with Excess of Blasts; Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion; Bone Marrow Diseases; Bone Marrow Transplantation; Combined Modality Therapy; Cytarabine; Etoposide; Female; Gastrointestinal Diseases; Humans; Idarubicin; Leukemia, Myeloid; Leukemia, Radiation-Induced; Male; Middle Aged; Neoplasms; Prospective Studies; Radiotherapy; Remission Induction; Salvage Therapy; Treatment Outcome | 1994 |
A randomized phase-III study of the efficacy of granulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia. Berlin-Frankfurt-Münster Study Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cytarabine; Daunorubicin; Dexamethasone; Disease-Free Survival; Etoposide; Female; Fever; Filgrastim; Gastrointestinal Diseases; Germany; Granulocyte Colony-Stimulating Factor; Hematologic Diseases; Humans; Ifosfamide; Infant; Infection Control; Life Tables; Male; Mercaptopurine; Methotrexate; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prospective Studies; Recombinant Proteins; Risk; Survival Analysis; Thioguanine; Vincristine; Vindesine | 1996 |
A randomized study of high-dose cytarabine in induction in acute myeloid leukemia.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Central Nervous System Diseases; Combined Modality Therapy; Cytarabine; Daunorubicin; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Etoposide; Eye Diseases; Female; Gastrointestinal Diseases; Humans; Leukemia, Myeloid; Life Tables; Male; Middle Aged; Remission Induction; Survival Analysis; Treatment Outcome | 1996 |
High-dose cytarabine and recombinant human granulocyte colony-stimulating factor for the treatment of resistant acute myelogenous leukemia.
Topics: Acute Disease; Adolescent; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytarabine; Disease-Free Survival; Female; Filgrastim; Gastrointestinal Diseases; Granulocyte Colony-Stimulating Factor; Humans; Immunologic Factors; Leukemia, Myeloid; Male; Middle Aged; Recombinant Proteins; Remission Induction; Salvage Therapy; Survival Rate; Treatment Outcome | 1996 |
Treatment with a new synthetic retinoid, Am80, of acute promyelocytic leukemia relapsed from complete remission induced by all-trans retinoic acid.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzoates; Cell Differentiation; Chemical and Drug Induced Liver Injury; Combined Modality Therapy; Cytarabine; Daunorubicin; Drug Resistance, Neoplasm; Female; Gastrointestinal Diseases; Humans; Leukemia, Promyelocytic, Acute; Leukocytosis; Male; Middle Aged; Pain; Prospective Studies; Receptors, Retinoic Acid; Recurrence; Remission Induction; Retinoic Acid Receptor gamma; Retinoids; Salvage Therapy; Tetrahydronaphthalenes; Treatment Outcome; Tretinoin | 1997 |
Cisplatin and infusional cytosine arabinoside for the treatment of colorectal adenocarcinoma: a phase II trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Chemical and Drug Induced Liver Injury; Cisplatin; Colorectal Neoplasms; Cytarabine; Drug Administration Schedule; Female; Gastrointestinal Diseases; Humans; Infusions, Intravenous; Male; Middle Aged; Treatment Failure | 1999 |
A prospective randomized trial of KRN8602 and cytosine arabinoside vs. daunorubicin and cytosine arabinoside in adult patients with newly diagnosed acute myelogenous leukemia. The KRN8602 Leukemia Study Group.
Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carubicin; Central Nervous System Diseases; Cytarabine; Daunorubicin; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Prospective Studies; Treatment Outcome | 1999 |
Mitoxantrone-DHAP with GM-CSF: an active but myelosuppressive salvage therapy for relapsed/refractory aggressive non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Dexamethasone; Disease-Free Survival; Drug Administration Schedule; Female; Gastrointestinal Diseases; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Humans; Life Tables; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Neutropenia; Remission Induction; Salvage Therapy; Sepsis; Survival Analysis; Thrombocytopenia; Treatment Outcome | 1999 |
Phase II evaluation of a high-dose mitoxantrone based induction regimen in untreated adults with acute myeloid leukemia.
Topics: Actuarial Analysis; Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Therapy; Conjunctivitis; Cytarabine; Disease-Free Survival; Etoposide; Female; Gastrointestinal Diseases; Humans; Hyperbilirubinemia; Leukemia, Myeloid; Male; Methylprednisolone; Middle Aged; Mitoxantrone; Remission Induction; Risk; Stomatitis; Stroke Volume; Survival Analysis; Survival Rate; Treatment Outcome; Tretinoin; Ventricular Dysfunction, Left | 2000 |
Carboplatinum and cytosine arabinoside in patients with disseminated malignant melanoma. A phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cytarabine; Drug Evaluation; Female; Gastrointestinal Diseases; Hematocrit; Humans; Male; Melanoma; Middle Aged; Platelet Count | 1991 |
26 other study(ies) available for cytarabine and Cholera Infantum
| Article | Year |
|---|---|
Gastrointestinal Adverse Events Observed After Chimeric Antigen Receptor T-Cell Therapy.
Topics: Adult; Age Distribution; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biopsy, Needle; Cohort Studies; Cytarabine; Daunorubicin; Female; Gastric Mucosa; Gastritis; Gastrointestinal Diseases; Hematologic Neoplasms; Humans; Immunohistochemistry; Immunotherapy, Adoptive; Incidence; Male; Middle Aged; Prognosis; Receptors, Chimeric Antigen; Retrospective Studies; Risk Assessment; Severity of Illness Index; Sex Distribution; Thioguanine | 2019 |
High-dose cytarabine as salvage therapy for relapsed or refractory acute myeloid leukemia--is more better or more of the same?
Topics: Adolescent; Adult; Allografts; Antimetabolites, Antineoplastic; Combined Modality Therapy; Cytarabine; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Dyspnea; Female; Gastrointestinal Diseases; Hematopoietic Stem Cell Transplantation; Humans; Infections; Kaplan-Meier Estimate; Keratitis; Leukemia, Myeloid, Acute; Male; Middle Aged; Recurrence; Remission Induction; Retrospective Studies; Salvage Therapy; Treatment Outcome; Xerophthalmia; Young Adult | 2016 |
[Infliximab therapy for Crohn's-like gastrointestinal lesions after allogeneic bone marrow transplantation].
Topics: Bone Marrow Transplantation; Cytarabine; Gastrointestinal Diseases; Graft vs Host Disease; Humans; Infliximab; Leukemia, Myeloid, Acute; Male; Middle Aged; Transplantation, Homologous | 2015 |
Weight patterns in children with higher risk ALL: A report from the Children's Oncology Group (COG) for CCG 1961.
Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Body Mass Index; Child; Child, Preschool; Cranial Irradiation; Cytarabine; Daunorubicin; Ethnicity; Female; Gastrointestinal Diseases; Glucose Intolerance; Humans; Incidence; Male; Methotrexate; Obesity; Pancreatitis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Randomized Controlled Trials as Topic; Retrospective Studies; Risk; Vincristine; Weight Gain; Weight Loss; Young Adult | 2009 |
Gastrointestinal involvement in disseminated Langerhans cell histiocytosis (LCH) with durable complete response to 2-chlorodeoxyadenosine and high-dose cytarabine.
Topics: Biopsy; Cladribine; Cytarabine; Drug Therapy, Combination; Gastrointestinal Diseases; Histiocytosis, Langerhans-Cell; Humans; Immunosuppressive Agents; Infant; Male | 2003 |
Improved outcome in childhood acute myeloid leukemia in Singapore with the MRC AML 10 protocol.
Topics: Acute Disease; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Cytarabine; Daunorubicin; Developing Countries; Disease-Free Survival; Drug Evaluation; Etoposide; Female; Gastrointestinal Diseases; Heart Diseases; Hematologic Diseases; Humans; Infant; Infections; Kaplan-Meier Estimate; Leukemia, Myeloid; Male; Mercaptopurine; Methotrexate; Mitoxantrone; Prednisone; Remission Induction; Retrospective Studies; Singapore; Survival Analysis; Thioguanine; Treatment Outcome; Vincristine | 2007 |
Cisplatin plus cytosine arabinoside in adults with malignant gliomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Bone Marrow Diseases; Brain Neoplasms; Cisplatin; Combined Modality Therapy; Cytarabine; Female; Gastrointestinal Diseases; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local | 1984 |
Phase I trial of cytarabine and hydroxyurea.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Child; Cytarabine; Drug Evaluation; Drug Resistance; Female; Gastrointestinal Diseases; Humans; Hydroxyurea; Leukemia; Lymphoma; Male; Middle Aged; Skin Diseases | 1983 |
Gastrointestinal necrosis in acute leukemia: a complication of induction therapy.
Topics: Cytarabine; Gastrointestinal Diseases; Humans; Leukemia; Necrosis | 1983 |
Clinical results and pharmacokinetics of high-dose cytosine arabinoside (HD ARA-C).
Topics: Adult; Arabinofuranosyluracil; Cytarabine; Drug Administration Schedule; Female; Gastrointestinal Diseases; Half-Life; Humans; Kinetics; Leukemia; Male; Metabolic Clearance Rate; Middle Aged; Teratoma; Time Factors | 1982 |
Improved outcome in adult B-cell acute lymphoblastic leukemia.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Bone Marrow Transplantation; Burkitt Lymphoma; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Female; Gastrointestinal Diseases; Humans; Ifosfamide; Leukemic Infiltration; Male; Meninges; Methotrexate; Middle Aged; Prednisone; Remission Induction; Stomatitis; Survival Analysis; Survival Rate; Teniposide; Treatment Outcome; Vincristine | 1996 |
Nutritional state alterations in children with acute lymphoblastic leukemia during induction and consolidation of chemotherapy.
Topics: Adolescent; Anthropometry; Antineoplastic Combined Chemotherapy Protocols; Arm; Asparaginase; Body Constitution; Child; Child, Preschool; Cohort Studies; Cytarabine; Drug Administration Schedule; Energy Metabolism; Epirubicin; Female; Gastrointestinal Diseases; Hospitals, General; Hospitals, Pediatric; Humans; Infant; Male; Mercaptopurine; Methotrexate; Nutrition Disorders; Nutritional Status; Obesity; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Risk; Skinfold Thickness; Vincristine | 1997 |
Salvage therapy for relapsed or refractory childhood acute lymphocytic leukemia by alternative administration a lymphoid- and myeloid-directed chemotherapeutic regimen consisting of dual modulation of ara-C, hydroxyurea, and etoposide.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Child; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Fever; Gastrointestinal Diseases; Humans; Hydrocortisone; Hydroxyurea; Leucovorin; Male; Methotrexate; Mitoxantrone; Pilot Projects; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Remission Induction; Salvage Therapy; Treatment Outcome | 1997 |
Early detection by ultrasound scan of severe post-chemotherapy gut complications in patients with acute leukemia.
Topics: Acute Disease; Adult; Anti-Infective Agents; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Dilatation, Pathologic; Enterocolitis; Etoposide; Female; Gallbladder Diseases; Gastrointestinal Diseases; Granulocyte Colony-Stimulating Factor; Humans; Idarubicin; Intubation, Gastrointestinal; Leukemia; Leukemia, Myelomonocytic, Acute; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Treatment Outcome; Ultrasonography | 1999 |
Cytosine arabinoside induced gastrointestinal toxic alterations in sequential chemotherapeutic protocols: a clinical-pathologic study of 33 patients.
Topics: Antineoplastic Agents; Bone Marrow; Cell Cycle; Cytarabine; Digestive System; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Humans; Infections; Infusions, Parenteral; Intestinal Mucosa; Kidney; Leukemia; Male; Serum Albumin; Water-Electrolyte Imbalance | 1978 |
Experimental gastrointestinal and disseminated candidiasis in immunocompromised animals.
Topics: Animals; Candida albicans; Candidiasis; Cytarabine; Disease Models, Animal; Female; Gastrointestinal Diseases; Gentamicins; Immunocompromised Host; Intestinal Mucosa; Methylprednisolone; Rabbits; Vancomycin | 1992 |
[Gastroenterologic findings in graft versus host disease after allogenic bone marrow transplantation].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Marrow Transplantation; Combined Modality Therapy; Cytarabine; Daunorubicin; Etoposide; Female; Gastrointestinal Diseases; Graft vs Host Disease; Humans; Infant, Newborn; Intestinal Mucosa; Leukemia, Myeloid, Acute; Liver; Pregnancy; Pregnancy Complications, Neoplastic; Sigmoidoscopy | 1991 |
Gastrointestinal complications of cytosine-arabinoside chemotherapy: findings on plain abdominal radiographs.
Topics: Adolescent; Adult; Cecal Diseases; Cytarabine; Female; Gastrointestinal Diseases; Gastrointestinal Hemorrhage; Humans; Intestinal Obstruction; Intestinal Pseudo-Obstruction; Male; Middle Aged; Peritonitis; Pneumatosis Cystoides Intestinalis; Pneumoperitoneum; Radiography; Stomach Diseases | 1990 |
A phase I study of intermittent continuous infusion high dose cytosine arabinoside for acute leukemia.
Topics: Adult; Blast Crisis; Cytarabine; Drug Evaluation; Female; Gastrointestinal Diseases; Humans; Infusions, Intravenous; Leukemia; Male; Middle Aged | 1990 |
Treatment of acute leukaemia with m-AMSA in combination with cytosine arabinoside.
Topics: Aged; Amsacrine; Chemical and Drug Induced Liver Injury; Cytarabine; Female; Gastrointestinal Diseases; Heart Diseases; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Male; Middle Aged; Neutropenia; Thrombocytopenia | 1986 |
High-dose cytosine arabinoside, daunomycin and 6-thioguanine in relapsed or refractory acute nonlymphocytic leukemia.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Diseases; Cytarabine; Daunorubicin; Gastrointestinal Diseases; Humans; Leukemia; Recurrence; Remission Induction; Thioguanine | 1987 |
[Gastrointestinal symptoms of aclacinomycin A in patients with adult acute nonlymphocytic leukemia--comparison of BH-AC-DMP therapy and BH-AC-AMP therapy].
Topics: Aclarubicin; Acute Disease; Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Digestive System; Female; Gastrointestinal Diseases; Humans; Leukemia; Male; Mercaptopurine; Naphthacenes; Prednisolone | 1985 |
Continuous infusion of high-dose cytosine arabinoside for treatment of childhood acute leukemia and non-Hodgkin's lymphoma in relapse.
Topics: Acute Disease; Adolescent; Adult; B-Lymphocytes; Bacterial Infections; Burkitt Lymphoma; Cerebellar Ataxia; Child; Child, Preschool; Cytarabine; Female; Gastrointestinal Diseases; Humans; Leukemia; Leukemia, Lymphoid; Lymphoma; Male; Neutropenia; Recurrence; Thrombocytopenia | 1985 |
How much is too much high-dose cytosine arabinoside?
Topics: Adult; Central Nervous System Diseases; Cytarabine; Gastrointestinal Diseases; Humans; Length of Stay; Leukemia; Meningeal Neoplasms; Pulmonary Edema | 1985 |
High-dose 1-beta-D-arabinofuranosylcytosine in advanced breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Cytarabine; Female; Gastrointestinal Diseases; Hematologic Diseases; Humans; Hypotension; Middle Aged | 1985 |
Cytarabine-cis-platin interactions in patients with advanced cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asthenia; Carcinoma, Bronchogenic; Cisplatin; Cytarabine; Dose-Response Relationship, Drug; Drug Evaluation; Female; Gastrointestinal Diseases; Humans; Kidney Diseases; Leukopenia; Lung Neoplasms; Lymphoma; Male; Middle Aged; Neoplasms; Neutropenia; Thrombocytopenia | 1985 |